Medical products manufacturer Bio-Rad Laboratories, Inc. BIO recently announced that the U.S. FDA has approved its latest D-100 System for HbA1c testing – a common blood test used to diagnose the ...
HERCULES, CA--(Marketwired - Jun 9, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced that its ...
HERCULES, CA--(Marketwired - December 16, 2015) - Bio-Rad Laboratories, Inc. (BIO) and (NYSE:BIO.B), a global provider of life science research and clinical diagnostic products, today announced that ...
DUBLIN--(BUSINESS WIRE)--The "Global POC HbA1C Testing Market 2017-2021" report has been added to Research and Markets' offering. The global POC HbA1C testing market to grow at a CAGR of 8.60% during ...
Medical products manufacturer Bio-Rad Laboratories, Inc.BIO recently announced that the U.S. FDA has approved its latest D-100 System for HbA1c testing - a common blood test used to diagnose the ...